1887
Rapid communication Open Access
Like 0

Abstract

Recent data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) show a large increase of +57% in species bloodstream infections in the European Union and European Economic Area in the first years of the COVID-19 pandemic (2020–2021) compared with 2018–2019. Most were resistant to carbapenems, from intensive care units, and in countries with ≥ 50% carbapenem resistance in spp. in 2018–2019. This highlights the requirement for reinforced preparedness and infection prevention and control in Europe.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2022.27.46.2200845
2022-11-17
2024-11-22
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2022.27.46.2200845
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/27/46/eurosurv-27-46-5.html?itemId=/content/10.2807/1560-7917.ES.2022.27.46.2200845&mimeType=html&fmt=ahah

References

  1. European Centre for Disease Prevention and Control (ECDC). Rapid risk assessment: Carbapenem-resistant Acinetobacter baumannii in healthcare settings – 8 December 2016. Stockholm: ECDC, 2016 Available from: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-carbapenem-resistant-acinetobacter-baumannii-healthcare
  2. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance in the EU/EEA (EARS-Net) - Annual epidemiological report for 2021. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/antimicrobial-resistance/surveillance-and-disease-data/report
  3. European Centre for Disease Prevention and Control (ECDC). TESSy – The European Surveillance System – antimicrobial resistance (AMR) reporting protocol 2022 – European Antimicrobial Resistance Surveillance Network (EARS-Net) surveillance data for 2021. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/en/publications-data/ears-net-reporting-protocol-2022
  4. European Centre for Disease Prevention and Control (ECDC). Surveillance atlas of infectious diseases. Stockholm: ECDC; 2022. Date accessed: 25 October 2022. Available from: https://www.ecdc.europa.eu/en/surveillance-atlas-infectious-diseases
  5. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-55.  https://doi.org/10.1016/S0140-6736(21)02724-0  PMID: 35065702 
  6. Mestrovic T, Robles Aguilar G, Swetschinski LR, Ikuta KS, Gray AP, Davis Weaver N, et al. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis. Lancet Public Health. 2022;7(11):e897-913.  https://doi.org/10.1016/S2468-2667(22)00225-0  PMID: 36244350 
  7. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56-66.  https://doi.org/10.1016/S1473-3099(18)30605-4  PMID: 30409683 
  8. Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS One. 2021;16(5):e0251170.  https://doi.org/10.1371/journal.pone.0251170  PMID: 33956882 
  9. O’Toole RF. The interface between COVID-19 and bacterial healthcare-associated infections. Clin Microbiol Infect. 2021;27(12):1772-6.  https://doi.org/10.1016/j.cmi.2021.06.001  PMID: 34111586 
  10. Protonotariou E, Mantzana P, Meletis G, Tychala A, Kassomenaki A, Vasilaki O, et al. Microbiological characteristics of bacteremias among COVID-19 hospitalized patients in a tertiary referral hospital in Northern Greece during the second epidemic wave. FEMS Microbes. 2021;2:xtab021.  https://doi.org/10.1093/femsmc/xtab021  PMID: 35311247 
  11. Lötsch F, Albiger B, Monnet DL, Struelens MJ, Seifert H, Kohlenberg A, et al. Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019. Euro Surveill. 2020;25(45):2001735.  https://doi.org/10.2807/1560-7917.ES.2020.25.45.2001735  PMID: 33183407 
  12. Lepape A, Jean A, De Waele J, Friggeri A, Savey A, Vanhems P, et al. European intensive care physicians’ experience of infections due to antibiotic-resistant bacteria. Antimicrob Resist Infect Control. 2020;9(1):1.  https://doi.org/10.1186/s13756-019-0662-8  PMID: 31908772 
  13. Leo CG, Sabina S, Tumolo MR, Bodini A, Ponzini G, Sabato E, et al. Burnout among healthcare workers in the COVID 19 era: A review of the existing literature. Front Public Health. 2021;9:750529.  https://doi.org/10.3389/fpubh.2021.750529  PMID: 34778184 
  14. Sexton JB, Adair KC, Proulx J, Profit J, Cui X, Bae J, et al. Emotional exhaustion among US health care workers before and during the COVID-19 pandemic, 2019-2021. JAMA Netw Open. 2022;5(9):e2232748.  https://doi.org/10.1001/jamanetworkopen.2022.32748  PMID: 36129705 
  15. Meda M, Gentry V, Reidy P, Garner D. Unintended consequences of long-sleeved gowns in a critical care setting during the COVID-19 pandemic. J Hosp Infect. 2020;106(3):605-9.  https://doi.org/10.1016/j.jhin.2020.07.036  PMID: 32745589 
  16. Perez S, Innes GK, Walters MS, Mehr J, Arias J, Greeley R, et al. Increase in hospital-acquired carbapenem-resistant Acinetobacter baumannii infection and colonization in an acute care hospital during a surge in COVID-19 admissions - New Jersey, February-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(48):1827-31.  https://doi.org/10.15585/mmwr.mm6948e1  PMID: 33270611 
  17. Tanne JH. Covid-19: Antimicrobial resistance rose dangerously in US during pandemic, CDC says. BMJ. 2022;378:o1755. . https://doi.org/10.1136/bmj.o1755  PMID: 35835472 
  18. Thoma R, Seneghini M, Seiffert SN, Vuichard Gysin D, Scanferla G, Haller S, et al. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature. Antimicrob Resist Infect Control. 2022;11(1):12.  https://doi.org/10.1186/s13756-022-01052-8  PMID: 35063032 
  19. Tomczyk S, Taylor A, Brown A, de Kraker MEA, El-Saed A, Alshamrani M, et al. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. J Antimicrob Chemother. 2021;76(11):3045-58. . https://doi.org/10.1093/jac/dkab300  PMID: 34473285 
  20. United States Centres for Disease Control and Prevention (US CDC). COVID-19: U.S. impact on antimicrobial resistance, special report 2022. Atlanta: CDC; 2022. Available from: https://stacks.cdc.gov/view/cdc/117915
  21. Langford BJ, So M, Raybardhan S, Leung V, Soucy JR, Westwood D, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27(4):520-31.  https://doi.org/10.1016/j.cmi.2020.12.018  PMID: 33418017 
  22. Brueggemann AB, Jansen van Rensburg MJ, Shaw D, McCarthy ND, Jolley KA, Maiden MCJ, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3(6):e360-70.  https://doi.org/10.1016/S2589-7500(21)00077-7  PMID: 34045002 
  23. Rybak A, Levy C, Angoulvant F, Auvrignon A, Gembara P, Danis K, et al. Association of nonpharmaceutical interventions during the COVID-19 pandemic with invasive pneumococcal disease, pneumococcal carriage, and respiratory viral infections among children in France. JAMA Netw Open. 2022;5(6):e2218959.  https://doi.org/10.1001/jamanetworkopen.2022.18959  PMID: 35763298 
  24. Meschiari M, Lòpez-Lozano JM, Di Pilato V, Gimenez-Esparza C, Vecchi E, Bacca E, et al. A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit. Antimicrob Resist Infect Control. 2021;10(1):123.  https://doi.org/10.1186/s13756-021-00990-z  PMID: 34412693 
/content/10.2807/1560-7917.ES.2022.27.46.2200845
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error